A vaccine under development has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work focuses on the H5N1 variant known as 2.3.4.4b, which has ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

Researchers evaluated the safety and immune response of a poultry-derived H5N1 avian influenza vaccine in black vultures and critically endangered California condors. The findings support the use of ...

A vaccine under development at the University at Buffalo has demonstrated complete protection in mice against a deadly ...

PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...

RALEIGH, N.C. (WTVD) -- The 2024-2025 flu season has been active and deadly in North Carolina. On Wednesday, the North Carolina Department of Health and Human Services (NCDHHS) said its latest ...

Although those vaccine materials were designed using versions of H5N1 flu from the early 2000s, a recent study suggests that they create an antibody response to the newer 2.3.4.4b versions that ...

NEW YORK, April 10: A new study from the Cleveland Clinic casts doubt on the effectiveness of the annual flu vaccine, which is typically recommended for all Americans aged 6 months and older by the ...

Three USDA employees from the National Animal Health Laboratory Network accepted buyouts and will leave by April 30, potentially impacting bird flu monitoring. These departures come amid a push by ...